Apr 23, 2025 4:06 PM
BACK TO TOP
KSE100
117,226.14
-1204.21
(-1.02%)
ALLSHR
73,365.85
-506.80
(-0.69%)
KSE30
36,019.66
-383.53
(-1.05%)
KMI30
176,989.57
-1908.99
(-1.07%)
BKTI
28,249.92
-336.25
(-1.18%)
OGTI
27,716.70
-163.48
(-0.59%)
KMIALLSHR
51,147.71
-322.15
(-0.63%)
PSXDIV20
44,760.24
-362.71
(-0.80%)
UPP9
37,279.39
-381.73
(-1.01%)
NITPGI
29,136.79
-257.33
(-0.88%)
NBPPGI
31,654.91
-289.07
(-0.90%)
MZNPI
21,792.29
-260.15
(-1.18%)
JSMFI
32,959.86
-468.85
(-1.40%)
ACI
19,290.73
-300.78
(-1.54%)
JSGBKTI
32,212.63
-446.35
(-1.37%)
MII30
16,319.73
-174.01
(-1.06%)
HBLTTI
16,517.43
22-04-2025
5.06
(0.03%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.92.50
-1.71
(-1.81%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Apr 23, 2025 3:47 PM
REG
FUT
ODL
Open
94.30
High
94.90
Low
92.00
Volume
3,451,888
CIRCUIT BREAKER
84.79 — 103.63
DAY RANGE
92.00 — 94.90
52-WEEK RANGE
24.11 — 109.30
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
94.21
VAR
15.00
HAIRCUT
22.50
P/E Ratio (TTM) **
25.69
1-Year Change *
279.41%
YTD Change *
35.81%
Last update: Wed, Apr 23, 2025 3:49 PM
Open
94.19
High
94.95
Low
92.30
Close
92.67
Change
-1.99%
LDCP
94.55
Volume
1,317,000
Total Trades
813
CIRCUIT BREAKER
85.10 — 104.01
DAY RANGE
92.30 — 94.95
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Wed, Apr 23, 2025 3:46 PM
Open
95.00
High
96.10
Low
93.55
Close
94.08
Change
-1.67%
LDCP
95.68
Volume
835,500
Total Trades
422
CIRCUIT BREAKER
86.11 — 105.25
DAY RANGE
93.55 — 96.10
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Ghulam DastgeerCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
21,132,661.00
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 3, 2025Transmission of Quarterly Financial Statements for the Half Year Ended 31 December 2024 View   PDF
Feb 28, 2025Financial Results for the Quarter ended December 31, 2024 View   PDF
Feb 12, 2025Half Yearly Progress Report for utilization of the proceeds for the half year ended December 31, 2023 View   PDF
Feb 11, 2025Half Yearly Progress Report for utilization of the proceeds for the half year ended December 30, 2023
REVOKED
View   PDF
Feb 11, 2025Annual Progress Report for the year ended June 30, 2024 View   PDF
Oct 31, 2024Transmission of Quarterly Report for the Period Ended View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended
REVOKED
View   PDF
Oct 30, 2024Financial Results for the Quarter Ended View   PDF
Oct 9, 2024Transmission of Annual Report for the Year Ended View   PDF
Oct 2, 2024Financial Results for the year ended View   PDF
DateTitleDocument
Apr 23, 2025Board Meeting View   
Feb 21, 2025Board Meeting View   
Feb 7, 2025Post meeting Briefing View   PDF
Feb 7, 2025Decision of the Board Meeting Held on 2025-02-06 View   PDF
Feb 6, 2025Board Meeting in Progress View   
Jan 30, 2025Board Meeting Other Than Financial Results View   PDF
Oct 30, 2024Board Meeting in Progress View   
Oct 23, 2024Board Meeting View   
Oct 7, 2024Notice of Annual General Meeting View   PDF
Oct 1, 2024Board Meeting in Progress View   
Sep 23, 2024Board Meeting View   
DateTitleDocument
Apr 16, 2025EXTRACT OF RESOLUTION PASSED VIA CIRCULATION View   PDF
Apr 16, 2025Material Information View   PDF
Mar 27, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 26, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Mar 4, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Feb 27, 2025Material Information View   PDF
Jan 23, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Dec 16, 2024Material Information View   PDF
Dec 10, 2024Material Information View   PDF
Dec 3, 2024Material Information View   PDF
Nov 25, 2024Miscellaneous Information View   PDF
Nov 22, 2024Miscellaneous Information
REVOKED
View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales12,409,23912,396,9839,779,8805,795,404
Profit after Taxation833,464657,984635,884351,768
EPS3.652.882.883.64
Q2 2025Q1 2025Q3 2024Q2 2024
Sales3,534,4323,224,6453,558,8743,275,165
Profit after Taxation256,979201,497211,345375,601
EPS1.120.880.931.64
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)12.7812.1613.8313.47
Net Profit Margin (%)6.725.316.506.07
EPS Growth (%)26.74(20.88)(88.58)
PEG0.29(0.54)(0.11)

Payouts

DateFinancial ResultsDetailsBook Closure
October 2, 2024 2:52 PM30/06/2024(YR) 32.50%(F) (D) 21/10/2024 - 28/10/2024
September 28, 2023 4:07 PM30/06/2023(YR) 25%(F) (D) 20/10/2023 - 27/10/2023
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports